DOI: 10.12890/2021_002350

Severe Complication of Thiopurine Treatment in a Young Woman with Crohn’s Disease

Authors

  • Michiel PJ Voet Department of Internal Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands
  • TGA Calon Department of Internal Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands
  • MMC Hendriks Department of Internal Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands
  • RM Schreuder Department of Gastroenterology and Hepatology, Catharina Ziekenhuis, Eindhoven, The Netherlands

michiel.voet@catharinaziekenhuis.nl

Keywords

Cytomegalovirus, thiopurine, pneumonitis, colitis, hepatitis

Abstract

Case Description: TA 28-year old woman receiving thiopurine treatment for Crohn’s disease presented with a systemic primo cytomegalovirus (CMV) infection affecting the gut (colitis), liver (hepatitis), lungs (pneumonitis) and eyes (retinitis). Secondary to this systemic infection, she developed splenomegaly, pancytopenia and lymphadenopathy. Anti-viral treatment resulted in complete resolution of clinical, biochemical and radiological abnormalities within 6 weeks. 
Conclusion: Early recognition is crucial since CMV infection in a patient receiving thiopurine treatment may result in serious complications.

View the entire article

Downloads

References

  1. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202–213.
  2. Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: Diagnosis and medical management. J Crohn’s Colitis 2017;11:3–25.
  3. Richtlijn diagnostiek en behandeling van inflammatoire darmziekten bij volwassenen. Haarlem: The Netherlands: Nederlandse Vereniging van Maag-Darm-Leverartsen; 2008.
  4. Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:2137–2142.
  5. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006;101:2857–2865.
  6. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008;5:1–7.
  7. Shukla T, Singh S, Tandon P, McCurdy JD. Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease. J Clin Gastroenterol 2017;51(5):394–401.
  8. Cascio A, Iaria C, Ruggeri P, Fries W. Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review. Int J Infect Dis 2012;16:e474–e479.
  9. Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009;374:1617–1625.
  10. Lum EL, Schaenman JM, DiNicola M, Reddy UG, Shen JI, Pullarkat ST. A case report of CMV lymphadenitis in an adult kidney transplant recipient. Transpl Proc 2015;47:141–145.
  11. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn’s Colitis 2009;3:47–91.
  12. Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, et al. Association of Crohn’s disease, thiopurines and primary EBV infection with hemophagocytic lymphohistiocytosis. J Pediatr 2011;159:808–812.
  13. Van Langenberg DR, Morrison G, Foley A, Buttigieg RJ, Gibson PR. Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: ‘A cocktail best avoided, not stirred’. J Crohn’s Colitis 2011;5:469–472.
  14. Abreu C, Sarmento A, Magro F. Screening, prophylaxis and counselling before the start of biological therapies: a practical approach focused on IBD patients. Dig Liver Dis 2017;49:1289–1297.

Published

2021-03-29

Issue

Vol. 8 No. 3 (2021)

How to Cite

1.
Voet MP, Calon T, Hendriks M, Schreuder R. Severe Complication of Thiopurine Treatment in a Young Woman with Crohn’s Disease. EJCRIM [Internet]. 2021 Mar. 29 [cited 2026 Nov. 3];8(3). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2350